When it comes to stem cells, the public -- and the media -- tend to focus on embryos. But researchers and analysts say marketable therapies already are emerging from less controversial work with adult stem cells.
It's shortly after 5 a.m. when the phone rings, and on the line is a clearly anxious and worried parent.
The Obama administration released a draft of guidelines for federal funding of human embryonic stem cell research Friday.
President Obama signed an executive order Monday repealing a Bush-era policy that limited federal tax dollars for embryonic stem cell research.
A top congressional Republican on Sunday criticized President Barack Obama's expected decision to reverse the Bush administration's limits on embryonic stem-cell research, calling it a distraction from the country's economic slump.
President Obama is planning to sign an executive order Monday to overturn Bush-era policy that limited federal tax dollars for embryonic stem cell research, according to administration officials familiar with the deliberations.
The Food and Drug Administration has approved the first human clinical trial of embryonic stem cell therapy. The stem cells used for this study came from the 60 existing stem cell lines approved in August 2001 by the Bush administration. Before that time, federal research dollars were not allowed to be used for stem cell research.
Federal regulators have cleared the way for the first human trials of human embryonic stem-cell research, authorizing researchers to test whether the cells are safe to use in spinal injury patients, the company behind the trials announced Friday.
Stem cells are considered a holy grail of medical research. They are thought to hold immense potential for treating a wide range of diseases and disabilities.
As well as their potential for creating effective therapies for debilitating diseases, embryonic stem cells could open the door to improved pharmaceutical drug testing, according to a leading British stem cell researcher.
When it comes to stem cells, the public -- and the media -- tend to focus on embryos. But researchers and analysts say marketable therapies already are emerging from less controversial work with adult stem cells.
It's shortly after 5 a.m. when the phone rings, and on the line is a clearly anxious and worried parent.
The Obama administration released a draft of guidelines for federal funding of human embryonic stem cell research Friday.
President Obama signed an executive order Monday repealing a Bush-era policy that limited federal tax dollars for embryonic stem cell research.
A top congressional Republican on Sunday criticized President Barack Obama's expected decision to reverse the Bush administration's limits on embryonic stem-cell research, calling it a distraction from the country's economic slump.
President Obama is planning to sign an executive order Monday to overturn Bush-era policy that limited federal tax dollars for embryonic stem cell research, according to administration officials familiar with the deliberations.
The Food and Drug Administration has approved the first human clinical trial of embryonic stem cell therapy. The stem cells used for this study came from the 60 existing stem cell lines approved in August 2001 by the Bush administration. Before that time, federal research dollars were not allowed to be used for stem cell research.
Federal regulators have cleared the way for the first human trials of human embryonic stem-cell research, authorizing researchers to test whether the cells are safe to use in spinal injury patients, the company behind the trials announced Friday.
Stem cells are considered a holy grail of medical research. They are thought to hold immense potential for treating a wide range of diseases and disabilities.
As well as their potential for creating effective therapies for debilitating diseases, embryonic stem cells could open the door to improved pharmaceutical drug testing, according to a leading British stem cell researcher.
Researchers create the first nerve cells out of reprogrammed stem cells, using a technique that bypasses the destruction of embryos
The Food and Drug Administration looks like it's bowing to the inevitable this week and drawing the blueprint for the first-ever human experiments with human embryonic stem cells.
It sounds like the stuff of Stephen King -- generating body parts, repairing damaged bone and growing back muscle like a gecko's severed tail. But stem cells represent a new wave of medicine that is more science than science fiction. One day they may not only lengthen an athlete's career but also provide the quick healing that Yankees pitcher Andy Pettitte was looking for when he used HGH to recover from elbow tendinitis in 2002.
Whoever wins the White House, stem cell biotechs stand to reap the benefit from an incoming leader who is friendlier to stem cell researchers than President Bush, and that could lift stocks for the entire sector, experts say.
The first experiments using human embryonic stem cells in human subjects could begin within a few months, the chief executive of biotech Geron said Monday.
The stem-cell breakthrough doesn't make up for six years of hypocrisy and lost research
The recent breakthroughs in stem cell research, where adult cells were "reprogrammed" to act like embryonic stem cells, are too early-stage to have much influence on Big Pharma's venture capital investments, experts say.
All sides involved in the controversy over the use of embryonic stem cells in research claimed vindication Tuesday after two teams of researchers reported having reprogrammed human skin cells to act like the stem cells, which have the potential of morphing into other cells and thereby curing disease.
In a pair of landmark studies, two groups of scientists announced Tuesday that they have reprogrammed human skin cells to act like embryonic stem cells, whose potential to mature into any other kind of cell in the body may ultimately prove key to curing a number of diseases.
Ever wanted to be a new you? Recent developments in cloning mean that day might be possible without therapy, a new diet or fitness regime.
Companies that develop drugs using embryonic stem cell research could soon enter a bold new phase: human testing.
What do you think the future holds for health? What developments are you hoping for? What challenges will we face? Send us your thoughts and we'll print the best ones here.
The questionable stem cells created by a disgraced Korean researcher turn out to be a bona fide medical breakthrough
Early-stage studies in mice have shown that adult blood could be a richer source of insulin-creating stem cells than fertilized eggs, according to Dr. Yong Zhao, assistant professor at the University of Illinois.
Pushing back against the Democratic-led Congress, President Bush vetoed a bill Wednesday that would have eased restraints on federally funded embryonic stem cell research
Is George W. Bush right to veto the easing of federal funding restrictions on stem cell research?
The latest findings may expand the ways of generating customized stem cells -- and defuse the ethical objections
A California company now offers IVF patients the option of creating and storing their own stem cells
Some of the biotechs specializing in stem cell research took a hit Thursday after the Senate voted to remove a ban on federal funding for embryonic stem cell research but not by a wide enough margin to overcome an expected presidential veto.
The Senate turned its attention to plans to loosen President Bush's 2001 limits on embryonic stem-cell research Tuesday, but sponsors conceded their chances of overriding a threatened veto are uncertain.
Two new stem cell treatments could be entering the U.S. market next year.
The U.S. House of Representatives voted in favor of a bill that would lift President Bush's funding restrictions on research involving embryonic stem cells.
Stock prices for biotechs involved in stem cell technology continued to surge Monday, after soaring the prior week, after a new source of stem cells was announced, and as the House prepares to vote on whether to loosen federal funding for research involving embryonic stem cells.
Last year, Hwang Woo-suk was Korea's scientific Superman. He had three institutes, a stamp created in his honor, and, over the years, $60 million at his disposal. His face was plastered on buses in...
It is a country where the call to prayer echoes throughout the capital every morning, where women must cover their heads at all times, where a Supreme Leader has the final say over everything.
The winners and losers from the mid-term elections weren't limited to the candidates on the ballots.
Voters in six states Tuesday approved ballot measures raising the minimum wage, joining 18 other states in setting a wage higher than the federal mark of $5.15 an hour, according to CNN projections.
The results of Missouri's referendum on stem cell research Tuesday could impact several biotechs specializing in that line of work.
After a nearly 20-year absence, Nixon-loving, Reagan-worshipping Alex P. Keaton is again slinging his political views on television.
Some key dates surrounding moral issues:
Moral issues sometimes drive voters to the polls not only to support or oppose a candidate, but also to make their voices heard on dozens of ballot measures dealing with issues like same-sex marriage, abortion or stem cell research.
Embryonic stem cells might hold the secrets to curing paralysis and brain damage, but they've also garnered plenty of controversy with the anti-abortion lobby because they're harvested from embryos.
In July, George W. Bush quashed a bill to fund stem cell research, his first veto as President. The issue should loom large come November. Here's the impact on U.S. biotech.
To its advocates, including British Prime Minister Tony Blair and Californian Governor Arnold Schwarzenegger, stem cell therapies promise a medical revolution that will enable all of us to live longer, healthier lives.
Stem-cell research has joined global warming and evolution science as fields in which the very facts are put to a vote, a public spectacle in which data wrestle dogma.
Geron Corp.'s stock price rose significantly after the biotech announced that its experimental, stem-cell-based therapy for spinal cord injuries is safe in rats.
President Bush used his veto power Wednesday for the first time since taking office 5 1/2 years ago, saying that an embryonic stem-cell research bill "crossed a moral boundary."
George W. Bush seldom suffered personally from doing what's unpopular politically. In fact, you could argue that he has made a career of it, holding fast to positions that many voters reject, as a sign of strength in these dangerous times. So his willingness to exercise his first-ever veto this week on a bill that would expand federal funding for human embryonic-stem-cell research, which 2 out of 3 voters favor, is not just a way to stroke his political base. "People like leadership much better than a finger in the wind," says White House press secretary Tony Snow. As Bush explained to him while in St. Petersburg, Russia, for the G-8 summit last week, "I took a position. I believe in it. So that's what I'm going to do."
Senate Majority Leader Bill Frist introduced a bill Thursday to expand funding for embryonic stem cell research and said it would be debated and voted on in July.
Paralyzed rats are walking again, thanks to a new stem cell treatment; that's big news for the medical community ... and a 10-year wait for anybody wanting to make a buck off it.
Paralyzed rats partially regained the use of a previously immobile hind leg in a study in which scientists injected the rodents with stem cells from mouse embryos, according to researchers at Johns Hopkins University.
Celgene Corp., a biotech specializing in stem cell research, patented its methods for recovering stem cells from a human placenta after birth, the company said.
The panel for the first CNN Future Summit program is set. Originating from Singapore, the one hour program will focus on the long-term impact of research into the fields of robotics, cybernetics, genetics and stem cells.
Despite the controversies surrounding it, stem cell research is already changing lives. In the future, it offers hope for cures and treatments for a variety of diseases and disorders. We want to know what you think about the promise of stem cell research.
Chances are very good you've heard about stem cells. Whether from reports of their almost miraculous ability to cure and restore, or very public controversies over their source or the research itself, stem cells have been a hot topic in the news for years.
British scientists are seeking permission to create hybrid embryos by fusing human cells with rabbit eggs.
Disgraced South Korean cloning scientist Hwang Woo-suk has apologized for publishing fake research on human stem cells, but said he was deceived by researchers at another lab.
South Korea's top university on Wednesday apologized for the scandal over Hwang Woo-suk's faked stem cell research, calling it a blemish on the country that embraced the scientist as a national hero.
One day after a panel investigating the work of disgraced South Korean scientist Hwang Woo-suk found that he faked claims of cloning human embryonic stem cells, the Seoul National University has issued a public apology.
A panel investigating the work of disgraced South Korean scientist Hwang Woo-suk has found that he faked claims of cloning human embryonic stem cells, in what could be the biggest cover-up in modern scientific history.
An expert panel from Seoul National University has dealt another blow to scientific claims by former researcher Hwang Woo-suk, saying he did not produce patient-specific stem cells as he had claimed in a landmark research paper.
An expert panel from Seoul National University has said that South Korean researcher Hwang Woo-suk falsified results of nine of 11 stem cell lines he claimed to have created, casting more doubts on breakthrough claims he made in the U.S. journal Science in May.
Former "Baywatch" star Brooke Burns, who broke her neck last month after diving into her backyard pool, credits a friend, a paramedic firefighter, with saving her life.
It may not be your average Christmas present or gift for a newborn baby, but a British-based company says grandparents looking for a gift with a twist are increasingly investing in stem cells for their grandchildren.
A prominent South Korean scientist is defending himself against allegations of fraud in the already controversial field of stem-cell research.
Hawaiian crooner Don Ho, who had an experimental procedure on his ailing heart earlier this week, says he's feeling much better and may return home to the islands within a few days.
Denise Villani was told she had a cancer that could not be cured, but three and a half years on, after taking part in a clinical trial for a vaccine, she is cancer-free. This is her story:
British surgeons hope a new procedure using stem cells from the lining of the nose will help mend severed nerves of paralyzed patients and may one day allow them to walk again.
Enormous advances are being made in all areas of technology on a daily basis. CNN's Human Technology special talks to some of the people whose lives have been affected by these innovations. Click on the links below to read their stories.
South Korea is making a concerted effort to apply the science of stem-cell research to finding the cure for terminal illnesses, but there is still a long way to go, according to a pioneering South Korean scientist.
Some of the biggest medical discoveries have come in the last 25 years -- everything from Viagra to laser vision correction.
Edward Bailey, 65, lost the sight in his left eye following a workplace accident. After two unsuccessful corneal transplants, he underwent a pioneering stem cell operation that restored his vision. Here is his story:
Two years ago Ian Rosenberg, from London, was told he had two and a half months to live. The 59-year-old had pioneering stem cell treatment which enabled his heart to repair damaged tissue.
Scientists in the U.S. have successfully used neural stem cells to regenerate damaged spinal cord tissue in mice, raising hopes that the technique could be used to treat disabilities caused by spinal cord injuries and human neurological disorders.
Stem cell science may be advancing, but not fast or far enough to break the standoff between President Bush and Congress over federal funding for research that destroys human embryos.
Lisa Altman couldn't sleep. On a Thursday night in late July, her husband was traveling, and the novel she'd been reading was keeping her awake. So At 5 A.M. she gave up, flipped on the television,...
A prominent Republican who had not been to Washington lately last week dropped into the capital, a city in the doldrums with both Congress and the president out of town. He was struck by one unexpected topic concentrating the attention of Republican insiders. It was not Iraq, Social Security or the Supreme Court.
NEW YORK (CNN/Money) - Biotech stock prices surged after Senate Majority Leader Bill Frist stated his support for a bill that would provide federal funding for stem cell research, but analysts urged investor caution even as they hailed the good news.
Assisted reproduction, in least in Europe, may be moving closer to the era of one-at-a-time babies.
American scientists have discovered a way of creating new brain cells in a dish -- a breakthrough that could lead to treatments for conditions such as Parkinson's disease and epilepsy.
Work on the possibility of cloning humans is dangerous, complicated and unethical and there will be no human clones this century, a South Korean stem cell research pioneer has said.
Sen. Arlen Specter said Sunday he believes the Senate has enough votes to override a threatened presidential veto of legislation easing restrictions on federal funding for embryonic stem cell research.
After impassioned debate, the House passed a controversial bill Tuesday that would expand public funding for embryonic stem cell research -- a measure President Bush threatened to veto last week.
A breakthrough in human embryonic stem cell research by scientists in South Korea has been hailed as ground-breaking, with the potential to fight a host of ailments, but some people have raised ethical concerns.
Biotechs specializing in stem cell research could see a jump in stock prices next week, say analysts who are keeping a close eye on a House bill that would lift limits on federal funding.
President Bush on Friday threatened to veto a bill expanding public funding for embryonic stem cell research that could make it to his desk by early next week.
The White House intends to threaten a veto on a House bill that would expand public funding for embryonic stem cell research beyond the limits President Bush set in 2001, two senior administration officials said Thursday.
It was the toughest call of his young presidency, and George Bush chose an event no less momentous than his first prime-time address to announce that he had found a thin ridge of moral high ground on which to perch.
In the next 10-20 years, we will see stem cell therapies applied to the major degenerative diseases of diabetes, congestive heart failure and Parkinson's disease.
A new technique that measures the elasticity of cells could revolutionize cancer detection and remove most of the guesswork in predicting if tumors are likely to spread.
The political frenzy on Capitol Hill surrounding House Majority Leader Tom DeLay's ethics is just the latest issue splintering Congressional Republicans.
The quiet of Easter recess on Capitol Hill was interrupted last week by stunning news that Republican leaders of the House had changed their position on allowing a vote for federal funding of human embryonic stem cell research opposed by President Bush.
Australian scientists have found that stem cells taken from adults could have the same life-saving potential as those taken from embryos, a discovery that could potentially end the contentious debate over embryonic research.
Stem cell research is a hot topic as countries weigh up the pros and cons of allowing scientists to carry out this controversial -- but potentially beneficial -- research.
It's 10.30 on Friday night, and scientists and doctors prepare to enter a veterinary hospital operating room at Seoul National University.
Since the December 3 meeting of President Bush's Council on Bioethics, the struggle over embryonic stem cell research has been altered.
Progress and setbacks marked the year in health, with several vaccines and drugs showing promise while officials pulled other products from the market.
THE DUSTY FLATLANDS of the Texas panhandle seem a world away from society's great debate about human stem cells. But if you want to see how stem cells could transform medicine, a ranch near Dalhart...
The head of a leading conservative group said Sunday that Sen. Arlen Specter "is a big-time problem" and that his quest to serve as chairman of the Senate Judiciary Committee "must be derailed."
John Kerry's defeat in the presidential election is battering companies involved in stem cell research -- despite passage of a California ballot proposal that would aggressively fund work on embryonic stem cells.
| Most Viewed | Most Emailed | Top Searches |
Video
